Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Effects of appendectomy on the course of ulcerative colitis and Crohn's disease

Independent teams of researchers from Australia and France find that a previous appendectomy may result in less severe ulcerative colitis, and additionally, delay disease onset in both ulcerative colitis and Crohn's disease.

News image

fiogf49gjkf04

Appendectomy reduces the risk of having ulcerative colitis (UC), however, its effect on the natural history of UC remains uncertain.

In this study, a team of researchers from France sought to determine whether appendectomy reduces the overall severity of UC.

They assessed 638 consecutive patients between 1997 and 2000.

10-year risk of colectomy:
- appendectomized = 16%
- non-appendectomized = 33%
Gut

The team determined appendectomy status and smoking habits by direct interview.

In addition they assessed severity of UC by reviewing therapeutic needs from the onset of colitis.

Furthermore, the team prospectively assessed the annual incidence of flare up, between 1997 and 2000, in patients who had not been colectomized.

The research team found that the 10-year risk of colectomy was 16% in 49 previously appendectomized patients, compared with 33% in 589 non-appendectomized patients.

Cox regression showed that previous appendectomy and current smoking were independent factors protecting against colectomy (adjusted hazard ratio, 0.40 and 0.60, respectively).

The team determined that respective proportions of appendectomized and non-appendectomized patients, who required oral steroids and immunosuppressive therapy were not significantly different (67% versus 70% and 27% versus 19%, respectively).

Between 1997 and 2000, UC was active for 48% of the time in appendectomized patients and for 62% of the time in non-appendectomized patients.

Prof. Cosnes's team concluded, "Previous appendectomy is associated with a less severe course of UC".

"The beneficial effect of appendectomy on the risk of colectomy is additive to that of current smoking".

Further to the previous study, researchers in Australia have compared appendectomy rates in inflammatory bowel disease patients, and evaluated the effect on disease characteristics. Their study is also published in the latest issue of Gut.

The research team identified study subjects from the Brisbane Inflammatory Bowel Disease database, and matched controls from the Australian Twin Registry.

They collected data on age at diagnosis, disease site, need for immunosuppression, and intestinal resection.

The research team confirmed the negative association between appendectomy and UC (odds ratio, 0.23), and also found a similar result for Crohn's disease, once the bias of appendectomy at diagnosis was addressed (OR, 0.34).

In addition, they determined that prior appendectomy delayed age of presentation for both diseases. This was statistically significant for Crohn's disease.

Furthermore, in UC, patients with prior appendectomy had clinically milder disease with reduced requirement for immunosuppression (OR 0.15) and proctocolectomy.

Dr Radford-Smith's team concluded, "Compared with patients without prior appendectomy, appendectomy before diagnosis delays disease onset in UC and Crohn's disease and gives rise to a milder disease phenotype in UC".

Gut 2002; 51: 803-7, 808-13
18 November 2002

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us